- Pfizer strikes Innovent deal worth up to $10.5B for a dozen cancer programsOn the eve of this year’s ASCO annual meeting, Pfizer said it is teaming up with China’s Innovent Biologics to advance a portfolio of 12 early-stage antibody-drug conjugates and multi-specific anti…Endpoints · 1mo ago↗ source
- Lilly obesity meds Foundayo and Zepbound to gain CVS coverageEli Lilly’s flagship obesity medications will be included in CVS Caremark formularies, likely boosting sales in the most competitive commercial drug market. The company announced Thursday that it…Endpoints · 2mo ago↗ source
- For wearables, it’s a GLP-1 worldWe have two pieces of wearables-related news for you today, and (maybe unsurprisingly) GLP-1s came up in our conversations with both companies. First, Signos raised $20 million for its approach ...